Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies

by I. S. Nosulenko, O. Yu. Voskoboynik, O. M. Antypenko, G. G. Berest, S. I. Kovalenko
Published 2015-02-01

Actoprotective activity of 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino-[2,3-c]quinazoline-2-ones

by O. S. Kolomoets, I. S. Nosulenko, О. Yu. Voskoboynik, G. G. Berest, S. I. Kovalenko, S. D. Trzhetsinsky
Published 2016-12-01

3'-R-Spiro[cycloalkyl-1(2), (hetaryl-3(4), 6'-[1,2,4]triazino[2,3-c]quinazoline]-2'(7'H)-2-оnes as a perspective class of compounds with actoprotective activity

by O. S. Kolomoets, О. Yu. Voskoboynik, I. S. Nosulenko, O. V. Krivoshey, A. I. Avramenko, G. G. Berest, S. I. Kovalenko
Published 2017-04-01

Trіazolo[1,5-c]quіnazolіnes Synthesis, antimicrobial and antifungal activity [quinazolin-4(3H)-ylidene]hydrazides of carboxylic acids (Message 1)

by K. P. Schabelnyk, S.V. Kholodnyak, G.G. Berest, S. І. Kоvalenko, N. M. Polishchuk, O. M. Kamyshnyі
Published 2018-06-01

2-([1,2,4]triazolo[1,5-c]quinazoline-2-yl-)alkyl-(alkaryl-,aryl-)-amines and their derivatives. Message 2. The synthesis of (3Н-quinazoline-4-ylidene)hydrazides N-protected aminoac...

by Yu. V. Martynenko, M. S. Kazunin, I. S. Nosulenko, G. G. Berest, S. І. Kоvalenko, O. M. Kamyshnyi, N. M. Polishchuk
Published 2018-06-01